Filing Flows › Insulet (PODD) › Drug Delivery revenue
Insulet (PODD) Drug Delivery revenue by quarter
Insulet's Drug Delivery revenue was $5.5M in Q3 2026 (third quarter 2026), -5% from Q2 2026. Over the last 7 quarters it ranged from $1.9M (Q4 2025) to $14.9M (Q1 2025).
| Quarter | Drug Delivery revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.5M | -5% | -23% |
| Q2 2026 | $5.8M | +76% | -43% |
| Q1 2026 | $3.3M | +74% | -78% |
| Q4 2025 | $1.9M | -73% | — |
| Q3 2025 | $7.1M | -30% | — |
| Q2 2025 | $10.2M | -32% | — |
| Q1 2025 | $14.9M | — | — |
Q3 2026 at a glance
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insulet's Drug Delivery revenue?
Insulet's Drug Delivery revenue was $5.5M in Q3 2026 (third quarter 2026), -5% from Q2 2026.
How has Insulet's Drug Delivery revenue changed?
Over the last 7 quarters it ranged from $1.9M (Q4 2025) to $14.9M (Q1 2025).